CLINICAL_TRIALS
trial_result
· 2020-02-11
Clinical Trial Update: Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1) [Phase 3]
Summary
Phase 3 SUNRISE 1 study evaluating the efficacy and safety of lemborexant in adults aged 55 and older with insomnia disorder has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Inc. | Conditions: Insomnia | Phase 3 | Status: COMPLETED | Results posted: 2020-02-11